Abstract
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, is a global public health threat and remains the leading cause of death among infectious diseases. The pathogen has developed strategies to survive inside and outside diverse host cells under wide range of unfavorable conditions, leading to persistence, and also undergo reactivation in the event of favorable conditions. Several sources of endogenous reactivation are proposed, including specific host cells that could harbor viable and dormant Mtb in the protective intracellular compartments. However, it is not clear how these host cells could survive the hypoxic/oxidative stress microenvironment prevalent in the post-drug treated granulomas. Recently Das et al. identified human CD271+ bone marrow mesenchymal stem cells (CD271+ BM-MSCs) as niche host cells that can maintain viable, non-replicating dormant Mtb. Most importantly, from patients who had successfully completed anti-tubercular therapy, viable Mtb could be isolated from CD271+ BM-MSCs, and not in other types of cells including macrophages. The follow-up study showed that Mtb could escape anti-tubercular drug therapy by hiding intracellular to CD271+ BM-MSCs serving as source for endogenous reactivation of TB. With these studies at the forefront, a novel model of granuloma reactivation could be proposed where CD271+ BM-MSCs harboring viable Mtb migrate to inflammatory granulomas for disease reactivation. Moreover, CD271+BM-MSCs also are able to resuscitate the viable but non-culturable (VBNC) Mtb inside the granuloma to reactivate the disease. Studies show that pulmonary tuberculosis (PTB) patients with culture negative sputum contain an occult population of VBNC Mtb in their sputum. CD271+ host-Mtb interaction studies suggest that these VBNC may be resuscitate back to culturable state by CD271+MSCs. Study of mechanism of Mtb survival and resuscitation inside MSCs is challenging and ongoing. Hypoxia may play an important role in the survival and persistence of Mtb inside the MSCs in TB patients post therapy as well in mice drug-induced dormancy model indicated by upregulation of HIF-1alpha. Latent TB has been challenging and difficult to study because of the dynamic capability of Mtb to adapt easily for over 200 years in vivo and in vitro. Despite all the ongoing efforts, so far, targeting dormant TB seems difficult. Although there are drugs which target cell wall synthesis, transcription, translation, and ATPase activity in actively dividing stage, their efficacy against dormant bacilli is unclear. Isoniazid treatment for 9 months is recommended for latent or dormant TB; however, non-adherence to such long regimen is a problem; moreover in light of current studies the efficacy of isoniazid against dormant bacilli is questionable. Studies on Mtb residing inside MSCs may shed light into new therapeutics to target non-replicating bacteria as well as VBNC Mtb and prevent endogenous reactivation of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altaf Bachh A, Gupta R, Haq I, Varudkar HG (2010) Diagnosing sputum/smear-negative pulmonary tuberculosis: Does fibre-optic bronchoscopy play a significant role? Lung India 27(2):58–62. https://doi.org/10.4103/0970-2113.63607
Antony VB, Sahn SA, Harada RN, Repine JE (1983) Lung repair and granuloma formation. Tubercle bacilli stimulated neutrophils release chemotactic factors for monocytes. Chest 83(5 Suppl):95S–96S
Beamer G, Major S, Das B, Campos-Neto A (2014) Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment. Am J Pathol 184(12):3170–3175. https://doi.org/10.1016/j.ajpath.2014.08.024
Beck F, Yegian D (1952) A study of the tubercle bacillus in resected pulmonary lesions. Am Rev Tuberc 66(1):44–51
Bloom BR, McKinney JD (1999) The death and resurrection of tuberculosis. Nat Med 5(8):872–874. https://doi.org/10.1038/11309
Cadena AM, Fortune SM, Flynn JL (2017) Heterogeneity in tuberculosis. Nat Rev Immunol 17(11):691–702. https://doi.org/10.1038/nri.2017.69
Chen Y, Zhang Y, Jiang TX, Barlow AJ, St Amand TR, Hu Y, Heaney S, Francis-West P, Chuong CM, Maas R (2000) Conservation of early odontogenic signaling pathways in Aves. Proc Natl Acad Sci USA 97(18):10044–10049. https://doi.org/10.1073/pnas.160245097
Das B (2000) The science behind squalene (The human antioxidant). ICBR
Das B, Kashino SS, Pulu I, Kalita D, Swami V, Yeger H, Felsher DW, Campos-Neto A (2013) CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis. Sci Transl Med 5(170):170ra113. https://doi.org/10.1126/scitranslmed.3004912
de Wit D, Wootton M, Dhillon J, Mitchison DA (1995) The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. Tuber Lung Dis 76(6):555–562
Dhillon J, Fourie PB, Mitchison DA (2014) Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media. J Antimicrob Chemother 69(2):437–440. https://doi.org/10.1093/jac/dkt357
Dooley SW Jr, Castro KG, Hutton MD, Mullan RJ, Polder JA, Snider DE Jr (1990) Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMRW Morb Mortal Wkly Rep 39(RR-17):1–29
Dutt AK, Stead WW (1994) Smear-negative pulmonary tuberculosis. Semin Respir Infect 9(2):113–119
Dutta NK, Karakousis PC (2014) Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev 78(3):343–371. https://doi.org/10.1128/MMBR.00010-14
Falk A, Tucker WB, Kaufman JE (1954) A clinical and bacteriologic correlation of resected pulmonary tuberculous lesions. Am Rev Tuberc 70(4):689–700
Fan XY, Tang BK, Xu YY, Han AX, Shi KX, Wu YK, Ye Y, Wei ML, Niu C, Wong KW, Zhao GP, Lyu LD (2018) Oxidation of dCTP contributes to antibiotic lethality in stationary-phase mycobacteria. Proc Natl Acad Sci USA 115(9):2210–2215. https://doi.org/10.1073/pnas.1719627115
Gao DZ, Fan RL (1986) Smear-positive and culture-negative results in detecting acid-fast bacilli in the sputum and their clinical significance. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi 9(6):374–376
Garhyan J, Bhuyan S, Pulu I, Kalita D, Das B, Bhatnagar R (2015) Preclinical and clinical evidence of Mycobacterium tuberculosis persistence in the hypoxic niche of bone marrow mesenchymal stem cells after therapy. Am J Pathol 185(7):1924–1934. https://doi.org/10.1016/j.ajpath.2015.03.028
Garton NJ, Waddell SJ, Sherratt AL, Lee SM, Smith RJ, Senner C, Hinds J, Rajakumar K, Adegbola RA, Besra GS, Butcher PD, Barer MR (2008) Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med 5(4):e75. https://doi.org/10.1371/journal.pmed.0050075
Gengenbacher M, Kaufmann SH (2012) Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev 36(3):514–532. https://doi.org/10.1111/j.1574-6976.2012.00331.x
Gong C, Linderman JJ, Kirschner D (2015) A population model capturing dynamics of tuberculosis granulomas predicts host infection outcomes. Math Biosci Eng 12(3):625–642. https://doi.org/10.3934/mbe.2015.12.625
Granville GE, Jenkins DE, Cooley DA, Debakey ME, Whitcomb FC, Halpert B (1953) Cultural properties of M. tuberculosis in resected pulmonary lesions of patients treated with streptomycin and para-aminosalicylic acid. Am Rev Tuberc 68(5):727–733
Grosset J (2003) Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob Agents Chemother 47(3):833–836
Hobby GL, Auerbach O, Lenert TF, Small MJ, Comer JV (1954) The late emergence of M. tuberculosis in liquid cultures of pulmonary lesions resected from humans. Am Rev Tuberc 70(2):191–218
Hurford JV, Valentine WH (1957) Viable tubercle bacilli in closed lesions. Tubercle 38(3):194–198
Islam N, Kanost AR, Teixeira L, Johnson J, Hejal R, Aung H, Wilkinson RJ, Hirsch CS, Toossi Z (2004) Role of cellular activation and tumor necrosis factor-alpha in the early expression of Mycobacterium tuberculosis 85B mRNA in human alveolar macrophages. J Infect Dis 190(2):341–351. https://doi.org/10.1086/421522
Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonca LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, Mailhot-Leonard F, Ahmed E, Belle J, Besla R, Mazer B, King IL, Nijnik A, Robbins CS, Barreiro LB, Divangahi M (2018) BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell 172 (1–2):176–190 e119. https://doi.org/10.1016/j.cell.2017.12.031
Khan A, Mann L, Papanna R, Lyu MA, Singh CR, Olson S, Eissa NT, Cirillo J, Das G, Hunter RL, Jagannath C (2017) Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy. Sci Rep 7(1):15010. https://doi.org/10.1038/s41598-017-15290-z
Lenaerts AJ, Hoff D, Aly S, Ehlers S, Andries K, Cantarero L, Orme IM, Basaraba RJ (2007) Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910. Antimicrob Agents Chemother 51(9):3338–3345. https://doi.org/10.1128/AAC.00276-07
Lenaerts A, Barry CE 3rd, Dartois V (2015) Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol Rev 264(1):288–307. https://doi.org/10.1111/imr.12252
Li S, Yue D, Chen X, Wang L, Li J, Ping Y, Gao Q, Wang D, Zhang T, Li F, Yang L, Huang L, Zhang Y (2015) Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity. Oncol Rep 33(1):425–432. https://doi.org/10.3892/or.2014.3569
Lin PL, Ford CB, Coleman MT, Myers AJ, Gawande R, Ioerger T, Sacchettini J, Fortune SM, Flynn JL (2014) Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 20(1):75–79. https://doi.org/10.1038/nm.3412
Mariotti S, Sargentini V, Pardini M, Giannoni F, De Spirito M, Gagliardi MC, Greco E, Teloni R, Fraziano M, Nisini R (2013) Mycobacterium tuberculosis may escape helper T cell recognition by infecting human fibroblasts. Hum Immunol 74(6):722–729. https://doi.org/10.1016/j.humimm.2013.02.005
Mayito J, Andia I, Belay M, Jolliffe DA, Kateete DP, Reece ST, Martineau AR (2019) Anatomic and cellular niches for mycobacterium tuberculosis in latent tuberculosis infection. J Infect Dis 219(5):685–694. https://doi.org/10.1093/infdis/jiy579
Mc DW (1959) In apparent infection: relation of latent and dormant infections to microbial persistence. Public Health Rep 74(6):485–499
Ministry of Health and Family Welfare DGoHS, Central TB Division (ed) (2007) TB India: RNTCP status report. Chapter 7, Performance of RNTCP
Mukamolova GV, Kaprelyants AS, Young DI, Young M, Kell DB (1998) A bacterial cytokine. Proc Natl Acad Sci USA 95(15):8916–8921
Mukamolova GV, Turapov O, Malkin J, Woltmann G, Barer MR (2010) Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum. Am J Respir Crit Care Med 181(2):174–180. https://doi.org/10.1164/rccm.200905-0661OC
Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F, Fornes P, Tailleux L, Barrios Payan JA, Pivert E, Bordat Y, Aguilar D, Prevost MC, Petit C, Gicquel B (2006) Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS One 1:e43. https://doi.org/10.1371/journal.pone.0000043
Nunes-Alves C, Booty MG, Carpenter SM, Jayaraman P, Rothchild AC, Behar SM (2014) In search of a new paradigm for protective immunity to TB. Nat Rev Microbiol 12(4):289–299. https://doi.org/10.1038/nrmicro3230
Pal B, Das B (2017) in vitro culture of naive human bone marrow mesenchymal stem cells: a Stemness based approach. Front Cell Dev Biol 5:69. https://doi.org/10.3389/fcell.2017.00069
Redmer T, Walz I, Klinger B, Khouja S, Welte Y, Schafer R, Regenbrecht C (2017) The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells. Oncogenesis 6(1):e291. https://doi.org/10.1038/oncsis.2016.88
Reece ST, Kaufmann SH (2012) Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis? Curr Opin Microbiol 15(1):63–70. https://doi.org/10.1016/j.mib.2011.10.006 S1369-5274(11)00176-7 [pii]
Russel WF, Dressler SH, Middlebrook G, Denst J (1955) Implications of the phenomenon of open cavity healing for the chemotherapy of pulmonary tuberculosis. Am Rev Tuberc 71(3, Part 1):441–446
Russell DG (2007) Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5(1):39–47. https://doi.org/10.1038/nrmicro1538
Salkin D, Wayne LG (1956) The bacteriology of resected tuberculous pulmonary lesions. I. The effect of interval between reversal of infectiousness and subsequent surgery. Am Rev Tuberc 74(3):376–387
Scanga CA, Mohan VP, Joseph H, Yu K, Chan J, Flynn JL (1999) Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun 67(9):4531–4538
Shi L, Sohaskey CD, Kana BD, Dawes S, North RJ, Mizrahi V, Gennaro ML (2005) Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci USA 102(43):15629–15634. https://doi.org/10.1073/pnas.0507850102
Shleeva MO, Bagramyan K, Telkov MV, Mukamolova GV, Young M, Kell DB, Kaprelyants AS (2002) Formation and resuscitation of “non-culturable” cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase. Microbiology 148(Pt 5):1581–1591. https://doi.org/10.1099/00221287-148-5-1581
Sia IG, Wieland ML (2011) Current concepts in the management of tuberculosis. Mayo Clin Proc 86 (4):348–361. https://doi.org/10.4065/mcp.2010.0820 S0025-6196(11)60013-X [pii]
Stewart GR, Robertson BD, Young DB (2003) Tuberculosis: a problem with persistence. Nat Rev Microbiol 1(2):97–105. https://doi.org/10.1038/nrmicro749
Sun Z, Zhang Y (1999) Spent culture supernatant of Mycobacterium tuberculosis H37Ra improves viability of aged cultures of this strain and allows small inocula to initiate growth. J Bacteriol 181(24):7626–7628
Vengattaraman S (2010) Diagnosing sputum/smear negative pulmonary tuberculosis. Lung India 27(4):263. https://doi.org/10.4103/0970-2113.71979
Wayne LG (1977) Synchronized replication of Mycobacterium tuberculosis. Infect Immun 17(3):528–530
Wayne LG, Hayes LG (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64(6):2062–2069
Wayne LG, Sohaskey CD (2001) Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol 55:139–163. https://doi.org/10.1146/annurev.micro.55.1.139
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Garhyan, J., Das, B., Bhatnagar, R. (2019). Mesenchymal Stem Cells: A Hidden Arsenal for Mtb Persistence, Resuscitation, and Reactivation. In: Hasnain, S., Ehtesham, N., Grover, S. (eds) Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions. Springer, Singapore. https://doi.org/10.1007/978-981-32-9413-4_17
Download citation
DOI: https://doi.org/10.1007/978-981-32-9413-4_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9412-7
Online ISBN: 978-981-32-9413-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)